Hepatitis B (HepB) is an international public health challenge that can lead to progressive scarring in hepatocellular carcinoma and primary liver cancer, and accounts for a significant proportion of viral hepatitis. The World Health Organization estimates that 296 million people were living with chronic hepatitis B infection in 2019, with about 820,000 deaths. About 90 million people in China suffer […]

It has been nearly three years since the outbreak of COVID-19 in 2020, during which time there have been several epidemic peaks triggered by mutated strains, especially the recent Omicron strain. Clinical data show that the Omicron strain is far more potent than influenza and other mutant strains of COVID-19, and that the strain can spread to about 9.5 people […]

Cervical cancer is the fourth largest malignant tumor harmful to women’s health, with a grim prevention and control situation. Although cervical cancer has a serious disease burden, it is relatively more preventable and controllable due to its relatively clear etiology. In 2020, the World Health Organization (WHO) officially issued the Global Strategy for the Accelerated Elimination of Cervical Cancer, specifying […]

According to statistics released by the WHO on April 23, recently, a total of 11 countries (especially the UK) have reported at least 169 cases of acute hepatitis of unknown cause in children. Along with the increase in the number of related cases, it is reported that one child has died of this disease. So far, the cause of this […]

I. Crucial virus strain in the new phase of the pandemic progression The Omicron strain has replaced the Delta strain as the predominant one circulating globally. Although several research teams and laboratories claim to have found recombinant viruses with mixed Delta and Omnicron variants in patients with Coronavirus, the transmissibility and pathogenicity of “Deltacron” is not yet clear, so mutations […]